Ascendis Pharma (ASND) PT Raised to $200 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Form 6-K Ascendis Pharma A/S For: Sep 16
September 16, 2024 7:32 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
... MoreForm 6-K Ascendis Pharma A/S For: Sep 16
September 16, 2024 7:29 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm 6-K Ascendis Pharma A/S For: Sep 11
September 12, 2024 6:01 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION... More
